Wells Fargo & Company Morphic Holding, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 12,081 shares of MORF stock, worth $411,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,081

Previous 11,963 0.99%

Holding current value

$411,599

Previous $345,000 23.19%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$26.64 - $40.31 $3,143 - $4,756	118 Added 0.99%	12,081 $425,000
Q4 2023 Feb 09, 2024	SELL	$19.95 - $31.0 $425,892 - $661,788	-21,348 Reduced 64.09%	11,963 $345,000
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $55,308 - $154,076	-2,593 Reduced 7.22%	33,311 $763,000
Q2 2023 Aug 15, 2023	BUY	$34.33 - $62.11 $701,018 - $1.27 Million	20,420 Added 131.88%	35,904 $2.06 Million
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $388,095 - $726,503	14,921 Added 2650.27%	15,484 $582,000

Q4 2022 Feb 13, 2023	SELL	$24.14 - $30.37 $24,864 - $31,281	-1,030 Reduced 64.66%	563 $15,000
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $4,846 - $7,274	-218 Reduced 12.04%	1,593 $45,000
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $168,401 - $366,918	-8,531 Reduced 82.49%	1,811 $40,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $275,427 - $395,247	-7,598 Reduced 42.35%	10,342 $416,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $359,314 - $545,738	-8,304 Reduced 31.64%	17,940 $850,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $1.2 Million - $1.52 Million	-22,450 Reduced 46.1%	26,244 $1.49 Million
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $17,465 - $25,151	387 Added 0.8%	48,694 $2.79 Million
Q1 2021 May 13, 2021	BUY	$29.77 - $84.85 $513,443 - $1.46 Million	17,247 Added 55.53%	48,307 $3.06 Million
Q4 2020 Feb 09, 2021	BUY	$25.66 - $34.55 $129,634 - $174,546	5,052 Added 19.42%	31,060 $1.04 Million
Q3 2020 Nov 05, 2020	SELL	$22.51 - $30.11 $84,232 - $112,671	-3,742 Reduced 12.58%	26,008 $711,000
Q2 2020 Aug 13, 2020	BUY	$12.65 - $29.57 $272,809 - $637,706	21,566 Added 263.51%	29,750 $805,000
Q1 2020 May 14, 2020	BUY	$10.84 - $20.85 $88,714 - $170,636	8,184 New	8,184 $120,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Morphic Holding, Inc. Transaction History